fbpx World Alzheimer's Month - September 2016 | Progress In Mind

World Alzheimer’s Month 2016

September 2016 will mark the 5th global World Alzheimer’s Month campaign - an international campaign to raise awareness for dementia and challenge stigma. Throughout the month Alzheimer's associations and other stakeholders organise advocacy and information events, as well as Memory Walks, media appearances and fundraising days. The impact of this campaign is growing, but the stigmatisation and misinformation that surrounds dementia remains a global issue. 

The theme for this year’s World Alzheimer’s Month campaign is Remember Me.

We’re encouraging people all around the world to understand the importance of memory as a hallmark of Alzheimer's disease, not to forget about loved ones who are living with the disease or who may have passed away.

Lundbeck is pleased to support the World Alzheimer’s Month as an official global sponsor. Follow the conversation on Twitter: #WAM2016 and #RememberMe

Marc Wortmann invites you to join World Alzheimer's Month

Marc Wortmann, Exeutive Director at Alzheimer's Disease International

WAM16 Marc Wortmann VID Invite

ALZHEIMER'S DISEASE FACT SHEET

Worldwide, 36 million people have dementia. Perhaps as many as 28 million of the world’s 36 million people with dementia have yet to receive a diagnosis and, therefore, do not have access to treatment, information and care.9

Alzheimer’s disease is the most common cause of dementia, accounting for 50–70% of cases.10  Alzheimer’s disease is a progressive brain disorder, in which the brain gradually degenerates. It most frequently occurs in people aged above 65–70 years. People with Alzheimer’s disease develop distressing changes in memory, thought, function and behaviour, which worsen over time. These changes increasingly impact upon the person’s daily life, reducing their independence, until ultimately they are entirely dependent on others.8

Alzheimer’s disease also has an enormous impact on the patient’s caregiver. Most caregivers are close relatives who provide care in the home – a demanding and exhausting role that represents a huge emotional and physical burden.8

Every year, an estimated 4.6 million new cases are identified. With the shift towards an increasingly elderly population, it is predicted that the number of people affected by dementia will almost double every 20 years, and by the year 2050, 115 million people will have the condition.9

The worldwide costs of dementia (US$604 billion in 2010) amount to more than 1% of gross domestic product (GDP).(2)  By 2018, the global cost of dementia will have increased to $818 billion, making the disease one of the most significant health crises of the 21st century.11

 

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

References
  1. http://www.who.int/mediacentre/factsheets/fs362/en/

  2. http://www.who.int/mediacentre/factsheets/fs362/en/

  3. Alzheimer Disease International. World Alzheimer Report 2011. The benefits of early diagnosis and intervention. Published by Alzheimer’s Disease International (ADI), September 2011.

  4. http://www.alz.org/alzheimers_disease_what_is_alzheimers.asp

  5. http://www.who.int/mediacentre/factsheets/fs362/en/

  6. http://www.who.int/mediacentre/factsheets/fs362/en/

  7. http://www.alz.org/alzheimers_disease_what_is_alzheimers.asp

  8. Georges J, Jansen S, Jackson J, et al. Alzheimer’s disease in real life – the dementia carer’s survey. Int J Geriatr Psychiatry 2008; 23 (5): 546–551

  9. Alzheimer Disease International. World Alzheimer Report 2011. The benefits of early diagnosis and intervention. Published by Alzheimer’s Disease International (ADI), September 2011. 

  10. Alzheimer’s Association. Basics of Alzheimer’s disease: http://www.alz.org/alzheimers_disease_what_is_alzheimers.asp

  11. Alzheimer Disease International. Dementia statistics. https://www.alz.co.uk/research/statistics

You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country